STOCK TITAN

Apnimed: Morningside reports 17.4% passive stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Apnimed, Inc. (APMD) is the issuer for which Morningside Venture Investments Limited reports beneficial ownership of 7,228,337 common shares, or 17.4%. The position comprises 7,152,713 shares directly owned by Morningside and 75,624 directly owned by its wholly owned subsidiary, MVIL, LLC. The reported percentage uses 41,630,779 Apnimed shares outstanding as of September 4, 2026.

Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, directors of Morningside, each report the same shares through shared voting and dispositive power, and each disclaims beneficial ownership of securities held by Morningside and MVIL, LLC. Morningside is ultimately wholly beneficially owned by a trust over which Adriel Wenbwo Chan and Wong Yuk Lan share authority to remove the trustee.

Beneficially owned shares 7,228,337 shares Reported by Morningside Venture Investments Limited and separately by each of four directors through shared voting and dispositive power.
Ownership percentage 17.4% Reported percentage for each reporting person, based on shares outstanding as of September 4, 2026.
Common shares outstanding 41,630,779 shares Apnimed shares outstanding as of September 4, 2026; basis for the reported 17.4%.
Shares directly owned by Morningside 7,152,713 shares Directly and beneficially owned by Morningside Venture Investments Limited.
Shares directly owned by MVIL, LLC 75,624 shares Directly and beneficially owned by Morningside's wholly owned subsidiary.
beneficial ownership regulatory
"Amount beneficially owned: 7,228,337"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
shared voting power regulatory
"Shared power to vote or to direct the vote"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive power regulatory
"Shared power to dispose or to direct the disposition"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many Apnimed (APMD) shares does Morningside report beneficially owning?

Morningside reports beneficial ownership of 7,228,337 APMD common shares, equal to 17.4% of the class. Of these, 7,152,713 are directly owned by Morningside and 75,624 are directly owned by its wholly owned subsidiary, MVIL, LLC.

Why do four Morningside directors each report the same APMD share amount?

Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho each report 7,228,337 shares because they share voting and dispositive power as Morningside directors. Each disclaims beneficial ownership of securities held by Morningside and MVIL, LLC.

What share count was used to calculate Morningside's 17.4% stake in APMD?

The reported 17.4% was based on 41,630,779 Apnimed common shares outstanding as of September 4, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





03770Y107

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: Percent of class represented by amount in row 9 is based on 41,630,779 shares of Common Stock, par value $0.00001 per share ("Common Stock"), outstanding as of September 4, 2026, as reported in the Issuer's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission (the "SEC") on September 8, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: Percent of class represented by amount in row 9 is based on 41,630,779 shares of Common Stock outstanding as of September 4, 2026, as reported in the Issuer's Quarterly Report on Form 10-Q filed with the SEC on September 8, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: Percent of class represented by amount in row 9 is based on 41,630,779 shares of Common Stock outstanding as of September 4, 2026, as reported in the Issuer's Quarterly Report on Form 10-Q filed with the SEC on September 8, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: Percent of class represented by amount in row 9 is based on 41,630,779 shares of Common Stock outstanding as of September 4, 2026, as reported in the Issuer's Quarterly Report on Form 10-Q filed with the SEC on September 8, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: Percent of class represented by amount in row 9 is based on 41,630,779 shares of Common Stock outstanding as of September 4, 2026, as reported in the Issuer's Quarterly Report on Form 10-Q filed with the SEC on September 8, 2026.


SCHEDULE 13G



Morningside Venture Investments Ltd
Signature:/s/ Frances Anne Elizabeth Richard
Name/Title:Frances Anne Elizabeth Richard, Director
Date:11/16/2026
Frances Anne Elizabeth Richard
Signature:/s/ Frances Anne Elizabeth Richard
Name/Title:Frances Anne Elizabeth Richard
Date:11/16/2026
Jill Marie Franklin
Signature:/s/ Jill Marie Franklin
Name/Title:Jill Marie Franklin
Date:11/16/2026
Peter Stuart Allenby Edwards
Signature:/s/ Peter Stuart Allenby Edwards
Name/Title:Peter Stuart Allenby Edwards
Date:11/16/2026
Cheung Ka Ho
Signature:/s/ Cheung Ka Ho
Name/Title:Cheung Ka Ho
Date:11/16/2026
Exhibit Information

Exhibit 1: Joint Filing Agreement, dated November 16, 2026

Keep reading